孕期体重增长与母婴结局的关联:系统综述与Meta分析
该系统综述与Meta分析检索1999年1月1日至2017年2月7日的观察性研究,纳入23项研究共1 309 136名孕妇,评估孕期体重增长高于或低于美国医学研究所(IOM)指南与母婴结局的关联。结果显示47%的孕妇体重增长高于指南、23%低于指南,高于或低于指南均与不良母婴结局风险升高相关。
要点
- 孕期体重增长低于IOM指南与小于胎龄儿(OR 1.53)和早产(OR 1.70)风险升高相关。
- 孕期体重增长高于IOM指南与大于胎龄儿(OR 1.85)、巨大儿(OR 1.95)和剖宫产(OR 1.30)风险升高相关。
- 23%的孕妇体重增长低于指南、47%高于指南,妊娠期糖尿病因数据性质无法评估。
研究设计与样本
- 系统综述、Meta分析与Meta回归,检索EMBASE、Evidence-Based Medicine Reviews、MEDLINE和MEDLINE In-Process于1999年1月1日至2017年2月7日发表的观察性研究。
- 共识别5354项研究,最终纳入23项研究,共1 309 136名孕妇,按孕前BMI分类和总孕期体重增长分层。
- 由2名独立评价者提取数据,基于有可用数据的研究子集,采用随机效应模型计算每活产的比值比(OR)和绝对风险差(ARD)。
主要发现
- 孕期体重增长低于指南与小于胎龄儿风险升高相关(OR 1.53 [95%CI 1.44-1.64];ARD 5% [95%CI 4%-6%])。
- 孕期体重增长低于指南与早产风险升高相关(OR 1.70 [95%CI 1.32-2.20];ARD 5% [95%CI 3%-8%]),与大于胎龄儿风险降低相关(OR 0.59 [95%CI 0.55-0.64];ARD -2% [95%CI -10%至-6%])。
- 孕期体重增长低于指南与巨大儿风险降低相关(OR 0.60 [95%CI 0.52-0.68];ARD -2% [95%CI -3%至-1%]),剖宫产无显著差异(OR 0.98 [95%CI 0.96-1.02];ARD 0% [95%CI -2%至1%])。
- 孕期体重增长高于指南与小于胎龄儿风险降低相关(OR 0.66 [95%CI 0.63-0.69];ARD -3% [95%CI -4%至-2%])和早产风险降低相关(OR 0.77 [95%CI 0.69-0.86];ARD -2% [95%CI -2%至-1%])。
- 孕期体重增长高于指南与大于胎龄儿风险升高相关(OR 1.85 [95%CI 1.76-1.95];ARD 4% [95%CI 2%-5%])、巨大儿风险升高相关(OR 1.95 [95%CI 1.79-2.11];ARD 6% [95%CI 4%-9%])和剖宫产风险升高相关(OR 1.30 [95%CI 1.25-1.35];ARD 4% [95%CI 3%-6%])。
关键数值与推荐
- IOM指南推荐孕期体重增长范围:体重不足女性(BMI<18.5)为12.5-18 kg;正常体重女性(BMI 18.5-24.9)为11.5-16 kg;超重女性(BMI 25-29.9)为7-11 kg;肥胖女性(BMI≥30)为5-9 kg。
临床怎么用
- 原文未据此给出推荐。
局限性
- 妊娠期糖尿病因现有数据的性质无法评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Body mass index (BMI) and gestational weight gain are increasing globally. In 2009, the Institute of Medicine (IOM) provided specific recommendations regarding the ideal gestational weight gain. However, the association between gestational weight gain consistent with theIOM guidelines and pregnancy outcomes is unclear. OBJECTIVE: To perform a systematic review, meta-analysis, and metaregression to evaluate associations between gestational weight gain above or below the IOM guidelines (gain of 12.5-18 kg for underweight women [BMI <18.5]; 11.5-16 kg for normal-weight women [BMI 18.5-24.9]; 7-11 kg for overweight women [BMI 25-29.9]; and 5-9 kg for obese women [BMI ≥30]) and maternal and infant outcomes. DATA SOURCES AND STUDY SELECTION: Search of EMBASE, Evidence-Based Medicine Reviews, MEDLINE, and MEDLINE In-Process between January 1, 1999, and February 7, 2017, for observational studies stratified by prepregnancy BMI category and total gestational weight gain. DATA EXTRACTION AND SYNTHESIS: Data were extracted by 2 independent reviewers. Odds ratios (ORs) and absolute risk differences (ARDs) per live birth were calculated using a random-effects model based on a subset of studies with available data. MAIN OUTCOMES AND MEASURES: Primary outcomes were small for gestational age (SGA), preterm birth, and large for gestational age (LGA). Secondary outcomes were macrosomia, cesarean delivery, and gestational diabetes mellitus. RESULTS: Of 5354 identified studies, 23 (n = 1 309 136 women) met inclusion criteria. Gestational weight gain was below or above guidelines in 23% and 47% of pregnancies, respectively. Gestational weight gain below the recommendations was associated with higher risk of SGA (OR, 1.53 [95% CI, 1.44-1.64]; ARD, 5% [95% CI, 4%-6%]) and preterm birth (OR, 1.70 [1.32-2.20]; ARD, 5% [3%-8%]) and lower risk of LGA (OR, 0.59 [0.55-0.64]; ARD, -2% [-10% to -6%]) and macrosomia (OR, 0.60 [0.52-0.68]; ARD, -2% [-3% to -1%]); cesarean delivery showed no significant difference (OR, 0.98 [0.96-1.02]; ARD, 0% [-2% to 1%]). Gestational weight gain above the recommendations was associated with lower risk of SGA (OR, 0.66 [0.63-0.69]; ARD, -3%; [-4% to -2%]) and preterm birth (OR, 0.77 [0.69-0.86]; ARD, -2% [-2% to -1%]) and higher risk of LGA (OR, 1.85 [1.76-1.95]; ARD, 4% [2%-5%]), macrosomia (OR, 1.95 [1.79-2.11]; ARD, 6% [4%-9%]), and cesarean delivery (OR, 1.30 [1.25-1.35]; ARD, 4% [3%-6%]). Gestational diabetes mellitus could not be evaluated because of the nature of available data. CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis of more than 1 million pregnant women, 47% had gestational weight gain greater than IOM recommendations and 23% had gestational weight gain less than IOM recommendations. Gestational weight gain greater than or less than guideline recommendations, compared with weight gain within recommended levels, was associated with higher risk of adverse maternal and infant outcomes.
引用
- Goldstein RF, Abell SK, Ranasinha S, et al. Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis. JAMA. 2017. PMID: 28586887. doi:10.1001/jama.2017.3635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。